Recent News: Clinical Research

Share
Print
and/or
21 News Items found
In the News
A crowd of people entering a large hall
ASH 2019 Roundup: The Latest on CAR T, New Treatments for CLL, and Using Genes to Predict a Common Side Effect
Read highlights of research presented by MSK scientists at the annual ASH meeting.
Feature
Model of TGF-beta molecule
An Old Protein Gets a New Look: Researchers Target TGF-ß to Make Immunotherapy More Effective
Drugs that block the action of TGF-ß may make checkpoint inhibitors more effective.
Finding
Alex Kentsis in his lab
Research Uncovers the Genetic Causes of Aggressive Leukemia in Children
Researchers have found that the genetic changes that cause pediatric leukemia are different from those that lead to leukemia in adults.
Roundup
2018
Top 10 Stories of 2018, Cancer Research Edition
Take a look back at some of the year’s biggest news in cancer research.
Roundup
ASH meeting signage
Advances in Myeloma, Lymphoma, and Bone Marrow Transplant Announced at the 2018 ASH Meeting
Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.
Feature
Side-by-side images of brain MRIs.
New Imaging Technique Provides Snapshot of Brain Tumor Activity
A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.
Finding
Leukemia cells
Findings from Two Patients Shed New Light on Drug Resistance in AML
A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.
In the Clinic
Chemical biologist Gabriela Chiosis in a laboratory
Experimental Cancer Drug Developed at MSK Leads to New Approach for Treating Alzheimer's Disease
A family of drugs developed at MSK targets disrupted processes in cells in diseases related to aging.
In the Clinic
Jedd Wolchok and Charlotte Ariyan in the lab
Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch
A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.
In the Clinic
Medical oncologist Jae Park
Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects
The study represents 20 years of research at MSK.